RobertBruceMontgomeryMD

Clinical Trials

• Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer Start of enrollment: 2005 Mar 01

  Completed

  Phase 2

• Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer Start of enrollment: 2009 Aug 01

  Recruiting

• Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2012 Dec 01

  Completed

  Phase 2

• Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2012 Mar 30

  Completed

  Phase 2

• Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2013 May 01

  Completed

  Not Applicable

• Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer Start of enrollment: 2013 Oct 01

  Completed

  Phase 1, Phase 2

• High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Start of enrollment: 2021 Aug 31

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss Start of enrollment: 2024 May 31

  Recruiting

  Phase 2

  Roles: Contact

• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer Start of enrollment: 2019 Oct 01

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all